Beneficiaries may need to meet requirements related to: Age Body mass index, or BMI A prescription for weight loss or maintaining weight reduction Use of the medication along with lifestyle modifications Other qualifying health conditions CMS guidance indicates that the program is designed for beneficiaries seeking GLP-1 medications solely to reduce excess body weight or maintain weight reduction
In 2024, it repositioned its product line to cater to people taking GLP-1 drugs for weight loss, hoping to attract customers and grow its business
In these cases, working with a local endocrinologist or bariatric specialist who can prescribe brand-name tirzepatide through insurance might be the better path
doi:10.25259/JCAS_144_2024 42
doi: 10.1111/dom.15113 14 PalmerSCTendalBMustafaRAVandvikPOLiSHaoQet al
This hormone is naturally produced in the gut and helps regulate blood sugar levels by increasing insulin secretion, slowing gastric emptying, and signaling the brain to reduce appetite
